Bicocca Open Archive

Logo unimib boa
SQUILLACE, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.369
EU - Europa 1.749
AS - Asia 679
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
AF - Africa 2
Totale 5.820
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.313
IT - Italia 420
DE - Germania 341
SE - Svezia 269
IE - Irlanda 252
SG - Singapore 220
CN - Cina 195
RU - Federazione Russa 181
HK - Hong Kong 109
GB - Regno Unito 76
VN - Vietnam 64
UA - Ucraina 57
CA - Canada 55
DK - Danimarca 41
FI - Finlandia 31
IN - India 31
ID - Indonesia 29
NL - Olanda 16
BE - Belgio 15
FR - Francia 11
TR - Turchia 8
PL - Polonia 7
AT - Austria 6
CO - Colombia 6
CH - Svizzera 5
CZ - Repubblica Ceca 4
IR - Iran 4
JP - Giappone 4
ES - Italia 3
EU - Europa 3
NZ - Nuova Zelanda 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BR - Brasile 2
BY - Bielorussia 2
CL - Cile 2
LT - Lituania 2
LU - Lussemburgo 2
MM - Myanmar 2
MY - Malesia 2
PE - Perù 2
TH - Thailandia 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BS - Bahamas 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 5.820
Salva come PNG Salva come JPEG
Città #
Ann Arbor 926
Frankfurt am Main 282
Fairfield 281
Dublin 243
Chandler 240
New York 226
Wilmington 193
Singapore 180
Ashburn 148
Woodbridge 142
Houston 132
Hong Kong 109
Seattle 102
Princeton 91
Santa Clara 88
Milan 77
Cambridge 75
Dearborn 56
Jacksonville 50
Dong Ket 41
Lawrence 41
Altamura 38
Shanghai 36
Jakarta 29
Nanjing 27
Guangzhou 25
San Diego 24
London 23
Ottawa 23
Fremont 18
Helsinki 18
Beijing 17
Rome 17
Los Angeles 16
Andover 14
Brussels 14
Falls Church 13
Boardman 11
Monza 11
Pune 10
Toronto 10
Lachine 9
Nanchang 9
Edmonton 8
Shenyang 8
Turin 8
Carate Brianza 7
Hangzhou 7
Jinan 7
Munich 7
Palermo 7
Casorate Primo 6
Naples 6
Acquafredda 5
Bogotá 5
Bresso 5
Florence 5
Gallarate 5
Kiev 5
Washington 5
Amsterdam 4
Casier 4
Changsha 4
Edinburgh 4
Hanoi 4
Hebei 4
Kunming 4
Lissone 4
Polska 4
San Francisco 4
Tianjin 4
Vienna 4
Zurich 4
Auckland 3
Cork 3
Frattamaggiore 3
Genoa 3
Genova 3
Glasgow 3
Kilburn 3
Lappeenranta 3
Leawood 3
Maastricht 3
Mariano Comense 3
Muggiò 3
Norwalk 3
Paris 3
Pioltello 3
Romola 3
Shenzhen 3
Stockholm 3
Tokyo 3
Albano Sant'Alessandro 2
Atlanta 2
Bangalore 2
Bangkok 2
Bari 2
Bhubaneswar 2
Busto Arsizio 2
Catania 2
Totale 4.366
Salva come PNG Salva come JPEG
Nome #
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 231
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 218
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 211
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 198
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 184
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare 184
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 181
Brachial and central blood pressure in HIV-infected subjects 179
Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated with the Evolution of Cognitive Performance in HIV-Infected Patients 173
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 171
Unmasking tuberculosis in the era of antiretroviral treatment 165
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 165
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 165
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 163
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 163
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances 161
Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? 156
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 133
The role for tocilizumab in covid-19 patients: Reflections on monza cohort data 128
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 124
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible from the STOPSHIV Project Cohort 109
Weight gain: A possible side effect of all antiretrovirals 106
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 103
Arterial structure and function in AIDS patients: the impact of renal damage. 98
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 98
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 96
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 95
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 94
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 93
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 93
Factors Associated With Weight Gain in People Treated With Dolutegravir 90
Factors associated with hospital admission for COVID-19 in HIV patients 88
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 87
A multidisciplinary approach to screen the post-COVID-19 conditions 86
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 86
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 85
Invecchiare con la terapia antiretrovirale o essere anziani in terapia antiretrovirale: due profili di comorbidità differenti? 84
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 81
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 74
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project 74
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 74
Arterial structural and functional effects of two different antiretroviral therapy protocol on naïve HIV-infected subjects 71
Early changes in adhesion molecules expression and endothelial function in patients initiating ART with Atazanavir or Lopinavir 70
Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19? 65
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 65
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 63
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile 55
Fattori associati con il ricovero ospedaliero per COVID-19 in 80 pazienti HIV-positivi italiani. Factors associated with hospital admission for COVID-19 in 80 Italian HIV patients. 54
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 50
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 43
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 41
Reversibility of Central Nervous System Adverse Events in Course of Art 41
HIV and SARS-CoV-2 Co-Infection: What are the Risks? 37
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study 34
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens 34
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? 34
Incident diabetes in course of antiretroviral therapy 29
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda 27
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 20
Totale 6.180
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020528 0 0 0 0 27 63 60 58 76 72 84 88
2020/20211.293 54 78 101 117 99 175 126 139 94 117 61 132
2021/2022692 75 63 82 61 19 48 18 34 18 60 68 146
2022/20231.272 135 346 108 104 67 193 23 103 84 21 50 38
2023/20241.037 51 18 69 29 119 315 165 48 83 27 7 106
2024/2025682 92 219 107 116 148 0 0 0 0 0 0 0
Totale 6.180